{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:59:39Z","timestamp":1790103579713,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.msard.2023.104567","type":"journal-article","created":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T17:22:58Z","timestamp":1676222578000},"page":"104567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-771X","authenticated-orcid":false,"given":"Yavor","family":"Yalachkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ansch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Maiworm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Schaller-Paule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hendrik","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Reil\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Friedauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Foerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104567_bib0001","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2009.04.004","article-title":"Interferon-\u03b2 therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism","volume":"211","author":"Azoulay","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.104567_bib0002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jneuroim.2008.01.010","article-title":"Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection","volume":"195","author":"Azoulay","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.104567_bib0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2005.07.001","article-title":"Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate","volume":"167","author":"Azoulay","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.104567_bib0004","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104567_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","author":"Bittner","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104567_bib0006","series-title":"Statistical Power Analysis For the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.msard.2023.104567_bib0007","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1177\/1352458518800815","article-title":"Age is a critical determinant in recovery from multiple sclerosis relapses","volume":"25","author":"Conway","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104567_bib0008","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1177\/13524585211000280","article-title":"Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis","volume":"27","author":"Cree","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104567_bib0009","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00415-018-9034-1","article-title":"The brief international cognitive assessment in multiple sclerosis (BICAMS): results from the German validation study","volume":"265","author":"Filser","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.104567_bib0010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40263-019-00675-7","article-title":"Fingolimod increases brain-derived neurotrophic factor level secretion from circulating T cells of patients with multiple sclerosis","volume":"33","author":"Golan","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.msard.2023.104567_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1352458518819380","article-title":"Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity","volume":"26","author":"H\u00f6gel","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104567_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103984","article-title":"Blood levels of brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis (MS): a systematic review and meta-analysis","volume":"65","author":"Karimi","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104567_bib0013","first-page":"404","article-title":"Noninvasive brain delivery and efficacy of BDNF to stimulate neuroregeneration and suppression of disease relapse in EAE mice","volume":"17","author":"Kopec","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.msard.2023.104567_bib0014","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.pharep.2019.03.005","article-title":"Oral administration of BDNF and\/or GDNF normalizes serum BDNF level in the olfactory bulbectomized rats: a proof of concept study","volume":"71","author":"Kucera","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.msard.2023.104567_bib0015","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104567_bib0016","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1177\/1352458519885613","article-title":"Neurofilament light levels are associated with long-term outcomes in multiple sclerosis","volume":"26","author":"Kuhle","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104567_bib0017","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpsychires.2006.01.014","article-title":"BDNF serum and CSF concentrations in Alzheimer\u2019s disease, normal pressure hydrocephalus and healthy controls","volume":"41","author":"Laske","year":"2007","journal-title":"J. Psychiatr Res."},{"key":"10.1016\/j.msard.2023.104567_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","author":"Lublin","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104567_bib0019","article-title":"Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients","author":"Meo","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.msard.2023.104567_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.msard.2023.104567_bib0021","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/acn3.51215","article-title":"Levels of brain-derived neurotrophic factor in patients with multiple sclerosis","volume":"7","author":"Naegelin","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2023.104567_bib0022","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.msard.2023.104567_bib0023","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.3390\/ijms21093079","article-title":"Fingolimod modulates dendritic architecture in a BDNF-dependent manner","volume":"21","author":"Patnaik","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2023.104567_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16278","article-title":"Association of serum neurofilament light levels with long-term brain atrophy in patients with a first multiple sclerosis episode","volume":"3","author":"Plavina","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.msard.2023.104567_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.917527","article-title":"A brief overview on BDNF-Trk pathway in the nervous system: a potential biomarker or possible target in treatment of multiple sclerosis?","volume":"13","author":"Schir\u00f2","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2023.104567_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264557","article-title":"Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: a systematic review and meta-analysis of exercise intervention trials","volume":"17","author":"Shobeiri","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2023.104567_bib0027","article-title":"Relapse recovery in multiple sclerosis: effect of treatment and contribution to long-term disability","volume":"7","author":"Sotiropoulos","year":"2021","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2023.104567_bib0028","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nrneurol.2017.139","article-title":"Achievements and obstacles of remyelinating therapies in multiple sclerosis","volume":"13","author":"Stangel","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2023.104567_bib0029","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2023.104567_bib0030","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/1352458512439119","article-title":"Natural, innate improvements in multiple sclerosis disability","volume":"18","author":"Tremlett","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104567_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101044","article-title":"Towards an understanding of the physical activity-BDNF-cognition triumvirate: a review of associations and dosage","volume":"60","author":"Walsh","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.msard.2023.104567_bib0032","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ene.12976","article-title":"Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training","volume":"23","author":"Wens","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2023.104567_bib0033","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/1352458520926869","article-title":"Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program","volume":"27","author":"Wiendl","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104567_bib0034","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1177\/1352458517707266","article-title":"Stop inflammation and you stop neurodegeneration in MS - YES","volume":"23","author":"Yong","year":"2017","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:03:50Z","timestamp":1761901430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"alternative-id":["S2211034823000718"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104567","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104567"}}